Adenomatous Polyposis Coli - 29 Studies Found

Not yet recruiting : Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
:
  • Attenuated Familial Adenomatous Polyposis
  • Familial : 2016-11-10
    :
    • Drug: Erlotinib Hydrochloride

Terminated : Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
:
  • Colorectal Cancer
  • Familial Adenomatous Polyposis

: 2002-04-09
:
  • Drug: Celecoxib Given 400 mg P
Active, not recruiting : Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)
:
  • Familial Adenomatous Polyposis
  • Colorectal Cancer

: 2007-09-04
:
  • Behavioral: Web-Based Multimedia Intervention

Completed : Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients
:
  • Colitis,Ulcerative
  • Adenomatous Polyposis Coli
  • Adenomatous Polyposis
    : 2005-11-11
    : Procedure: flexible sigmoidoscopy
Terminated : Coxib-inhibition of Duodenal Polyp Growth in FAP
: Duodenal Polyposis
: 2009-02-13
:
  • Drug: Rofecoxib
  • Drug: placebo

Completed : A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers
: Healthy Volunteers
: 2008-12-22
:
  • Drug: celecoxib reference formulation

Recruiting : Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
:
  • Colorectal Cancer
  • Hereditary Nonpolyposis Colorectal Cancer
  • Other: study of socioeconomic and demographic variables

Terminated : Ileal Pouch-Anal Anastomosis Registry
: Ileal Pouch-Anal Anastomosis
: 2009-11-25
<<< Previous